Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients.

Pavlos ZarogoulidisDimitrios PetridisChristoforos KosmidisKonstantinos SapalidisLila NenaDimitrios MatthaiosΚonstantinos PorpodisPaschalis KakavelasPaschalis Steiropoulos

Published in: Current oncology (Toronto, Ont.) (2023)

Immunotherapy drugs on their own do not induce sleep disturbances and, through treatment response, alleviate sleep disturbances in lung cancer patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
small cell lung cancer
prognostic factors
squamous cell carcinoma
patient reported outcomes
radiation therapy
patient reported
locally advanced
advanced non small cell lung cancer
rectal cancer
tyrosine kinase